Erratum to: Mechanisms by which HIV envelope minimizes immunogenicity (Immunologic Research DOI: 10.1007/s12026-010-8178-6);Mechanisms by which HIV envelope minimizes immunogenicity

Immunologic Research

Volumn 49, Issue 1-3, 2011, Pages 147-158

  Jiang, Haixiang ^a   Liao, Larry ^a   Montefiori, David C ^a   Frank, Michael M ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

HIV envelope proteins; HIV vaccines

Indexed keywords

CD59 ANTIGEN; COMPLEMENT COMPONENT C1Q; DECAY ACCELERATING FACTOR; GLYCOPROTEIN GP 140; MANNAN; MANNOSE BINDING LECTIN; MEMBRANE COFACTOR PROTEIN; OPSONIN; OVALBUMIN; VIRUS ENVELOPE PROTEIN;

ANTIBODY RESPONSE; ARTICLE; COMPLEMENT FIXATION; ENZYME LINKED IMMUNOSORBENT ASSAY; GERMINAL CENTER; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNOGENICITY; ISOTOPE LABELING; MEMORY CELL; NONHUMAN; PHAGOCYTE; PRIORITY JOURNAL; PROTEIN BINDING; VIRUS ATTACHMENT; VIRUS ENVELOPE; VIRUS INFECTIVITY; VIRUS STRAIN;

EID: 79952696872     PISSN: 0257277X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12026-010-8202-x     Document Type: Erratum

References (27)

1. Johnston MI, Fauci AS. An HIV vaccine-evolving concepts. N Engl J Med. 2007;356:2073-81.
2. Fauci AS, Johnston MI, Dieffenbach CW, et al. HIV vaccine research: the way forward. Science. 2008;321:530-2.
3. Carroll M. The complement system in regulation of adaptive immunity. Nat Immunol. 2004;5:981-6. (Pubitemid 41057714)
4. Ochs HD, Wedgwood RJ, Frank MM, Heller SR, Hosea SW. The role of complement in the induction of antibody responses. Clin Exp Immunol. 1983;53:208-16. (Pubitemid 13106768)
5. Ochs HD, Nonoyama S, Zhu Q, Farrington M, Wedgwood RJ. Regulation of antibody responses: the role of complement and adhesion molecules. Clin Immunol Immunopathol. 1993;67:S33-40.
6. Chen Z, Koralov SB, Gendelman M, Carroll MC, Kelsoe G. Humoral immune responses in Cr2-/- mice: enhanced affinity maturation but impaired antibody persistence. J Immunol. 2000;164:4522-32. (Pubitemid 30238048)
7. Dempsey PW, Allison ME, Akkaraju S, Goodnow CC, Fearon DT. C3d of complement as a molecular adjuvant: bridging innate and acquired immunity. Science. 1996;271:348-50.
8. Phan TG, Grigorova I, Okada T, Cyster JG. Subcapsular encounter and complement-dependent transport of immune complexes by lymph node B cells. Nat Immunol. 2007;8:992-1000. (Pubitemid 47300014)
9. Phan TG, Gray EE, Cyster JG. The microanatomy of B cell activation. Curr Opin Immunol. 2009;21:258-65.
10. Stoiber H, Pruenster M, Ammann CG, Dierich MP. Complement-opsonized HIV: the free rider on its way to infection. Mol Immunol. 2005;42:153-60.
11. Susal C, Kirschfink M, Kropelin M, Daniel V, Opelz G. Identification of complement activation sites in human immunodeficiency virus type-1 glycoprotein gp120. Blood. 1996;87:2329-36. (Pubitemid 26086874)
12. Thieblemont N, Haeffner-Cavaillon N, Weiss L, Maillet F, Kazatchkine MD. Complement activation by gp160 glycoprotein of HIV-1. AIDS Res Hum Retroviruses. 1993;9:229-33. (Pubitemid 23108516)
13. Ying H, Ji X, Hart ML, et al. Interaction of mannose-binding lectin with HIV type 1 is sufficient for virus opsonization but not neutralization. AIDS Res Hum Retroviruses. 2004;20:327-35. (Pubitemid 38429405)
14. Boyer V, Desgranges C, Trabaud MA, Fischer E, Kazatchkine MD. Complement mediates human immunodeficiency virus type 1 infection of a human T cell line in a CD4- and antibody-independent fashion. J Exp Med. 1991;173:1151-8.
15. Hessell AJ, Hangartner L, Hunter M, et al. Fc receptor but not complement binding is important in antibody protection against HIV. Nature. 2007;449:101-4. (Pubitemid 47373775)
16. Montefiori DC, Cornell RJ, Zhou JY, Zhou JT, Hirsch VM, Johnson PR. Complement control proteins, CD46, CD55, and CD59, as common surface constituents of human and simian immunodeficiency viruses and possible targets for vaccine protection. Virology. 1994;205:82-92. (Pubitemid 24360593)
17. Saifuddin M, Hedayati T, Atkinson JP, Holguin MH, Parker CJ, Spear GT. Human immunodeficiency virus type 1 incorporates both glycosyl phosphatidylinositol-anchored CD55 and CD59 and integral membrane CD46 at levels that protect from complement-mediated destruction. J Gen Virol. 1997;78(Pt 8):1907-11. (Pubitemid 27367673)
18. Stoiber H, Schneider R, Janatova J, Dierich MP. Human complement proteins C3b, C4b, factor H and properdin react with specific sites in gp120 and gp41, the envelope proteins of HIV-1. Immunobiology. 1995;193:98-113.
19. Salazar-Gonzalez JF, Bailes E, Pham KT, et al. Deciphering human immunodeficiency virus type 1 transmission and early envelope diversification by single-genome amplification and sequencing. J Virol. 2008;82:3952-70. (Pubitemid 351521232)
20. Ansari AA, Hattikudur NS, Joshi SR, Medeira MA. ELISA solid phase: stability and binding characteristics. J Immunol Methods. 1985;84:117-24. (Pubitemid 16180281)
21. Dierks SE, Butler JE, Richerson HB. Altered recognition of surface-adsorbed compared to antigenbound antibodies in the ELISA. Mol Immunol. 1986;23:403-11. (Pubitemid 16142912)
22. Mayer MM, editor. Complement and complement fixation. 2nd ed. Springfield, IL: Charles C. Thomas; 1961.
23. Ashwell G, Harford J. Carbohydrate-specific receptors of the liver. Annu Rev Biochem. 1982;51:531-54.
24. Snyder GA, Ford J, Torabi-Parizi P, et al. Characterization of DC-SIGN/R interaction with human immunodeficiency virus type 1 gp120 and ICAM molecules favors the receptor's role as an antigencapturing rather than an adhesion receptor. J Virol. 2005;79:4589-98. (Pubitemid 40464210)
25. Minden P, Anthony BF, Farr RS. A comparison of seven procedures to detect the primary binding of antigen by antibody. J Immunol. 1969;102:832-41.
26. Hladik F, McElrath MJ. Setting the stage: host invasion by HIV. Nat Rev Immunol. 2008;8:447-57. (Pubitemid 351735878)
27. Bonsignori M, Moody MA, Parks RJ, et al. HIV-1 envelope induces memory B cell responses that correlate with plasma antibody levels after envelope gp120 protein vaccination or HIV-1 infection. J Immunol. 2009;183:2708-17.